SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-026957
Filing Date
2024-05-21
Accepted
2024-05-21 08:20:22
Documents
14
Period of Report
2024-05-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20029602_8k.htm   iXBRL 8-K 37371
2 EXHIBIT 10.1 ef20029602_ex10-1.htm EX-10.1 49479
  Complete submission text file 0001140361-24-026957.txt   239215

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA kron-20240520.xsd EX-101.SCH 3868
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE kron-20240520_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kron-20240520_pre.xml EX-101.PRE 16046
17 EXTRACTED XBRL INSTANCE DOCUMENT ef20029602_8k_htm.xml XML 4227
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 (650) 781-5200
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39592 | Film No.: 24966904
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)